CAS 15717-45-0
:Guanosine, 8-bromo-, 2′,3′,5′-triacétate
- 2',3',5'-tri-O-acetyl-8-bromoguanosine
- 2-amino-8-bromo-9-(2,3,5-tri-O-acetylpentofuranosyl)-3,9-dihydro-6H-purin-6-one
- 2′,3′,5′-Tri-O-acetyl-8-bromoguanosine
- 8-Bromo-2′,3′,5′-tri-O-acetylguanosine
- 8-Bromoguanosine 2',3',5'-triacetate
- 8-Bromoguanosine 2′,3′,5′-triacetate
- Guanosine, 8-bromo-, 2′,3′,5′-triacetate
- NSC 174056
- NSC 79210
Guanosine, 8-bromo-, 2',3',5'-triacetate
CAS :Formule :C16H18BrN5O8Degré de pureté :95%Couleur et forme :SolidMasse moléculaire :488.2468(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-8-bromo-6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-3,4-diyl diacetate
CAS :(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-8-bromo-6-oxo-1H-purin-9(6H)-yl)tetrahydrofuran-3,4-diyl diacetateDegré de pureté :95%Masse moléculaire :488.25g/mol8-Bromo-2’,3’,5’-tri-O-acetylguanosine-13C2,15N
CAS :Produit contrôléApplications 8-Bromo-2’,3’,5’-tri-O-acetylguanosine-13C2,15N is an intermediate in the synthesis of 8-Aminoguanosine-13C2,15N (A609877). 8-Aminoguanosine-13C2,15N is an isotopic labelled compound of 8-Aminoguanosine (A609875), which is a potent inhibitor of purine nucleoside phosphorylase. 8-Bromo-2’,3’,5’-tri-O-acetylguanosine-13C2,15N is also a labelled analog of 8-Bromo-2’,3’,5’-tri-O-acetylguanosine (B688325).
References Kazmers, I.S., et al.: Science, 214, 1137 (1981); Chern, J-W., et al.: J. Med. Chem., 36, 1024 (1993)Formule :C2C14H18Br15NN4O8Couleur et forme :NeatMasse moléculaire :491.2268-Bromo-2’,3’,5’-tri-O-acetylguanosine
CAS :Produit contrôléApplications 8-Bromo-2’,3’,5’-tri-O-acetylguanosine (cas# 15717-45-0) is a compound useful in organic synthesis.
References Kazmers, I.S., et al.: Science, 214, 1137 (1981), Chern, J-W., et al.: J. Med. Chem., 36, 1024 (1993)Formule :C16H18BrN5O8Couleur et forme :NeatMasse moléculaire :488.252',3',5'-Tri-O-acetyl-8-bromoguanosine
CAS :2',3',5'-Tri-O-acetyl-8-bromoguanosine is a synthetic nucleoside analog that inhibits the growth of tumor cells. It has been shown to inhibit the progression of prostate cancer and cervical cancer by binding to guanosine, preventing its conversion into ATP. This compound also prevents proliferation in hek293 and glioblastoma cells. The mechanism of action may be due to oxidative phosphite formation, which causes DNA damage and subsequent apoptosis.
Formule :C16H18BrN5O8Degré de pureté :Min. 95%Couleur et forme :Off-White To Light (Or Pale) Yellow SolidMasse moléculaire :488.25 g/mol




